I don't think there is a chance in hell... I would say it's 0% that Si sells GvHD or Reme as a product, or allows a takeover. Licensing on the other hand I think is on the cards, and I do think they will effectively sell Rexlemestrocel for example for the CHF indication to another company, or partner up and profit share because they need to if they want to get into the market and not take another 10 years to do it.
SI has consistently said that the way forward will be partnerships.
Everything he has done so far has been to underpin that and to put MSB in the strongest possible negotiating position for the best LT outcome for shareholders. IMO
- Forums
- ASX - By Stock
- MSB
- Ann: FDA Schedules GvHD Pre-License Manufacturing Inspection
Ann: FDA Schedules GvHD Pre-License Manufacturing Inspection, page-228
-
- There are more pages in this discussion • 48 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
92.0¢ |
Change
-0.020(2.13%) |
Mkt cap ! $1.050B |
Open | High | Low | Value | Volume |
95.0¢ | 95.0¢ | 91.8¢ | $1.818M | 1.964M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 294829 | 92.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
92.5¢ | 5000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 244829 | 0.920 |
15 | 213029 | 0.915 |
16 | 212064 | 0.910 |
5 | 47641 | 0.905 |
34 | 207702 | 0.900 |
Price($) | Vol. | No. |
---|---|---|
0.925 | 5000 | 1 |
0.930 | 67393 | 4 |
0.935 | 82215 | 6 |
0.940 | 52117 | 6 |
0.945 | 79884 | 4 |
Last trade - 16.10pm 16/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |